SCHEMBL6541187

SCHEMBL6541187

COC(=O)c1ccc(S(=O)(=O)c2ccc(CCN(Cc3ccccc3)C[C@@H](O)c3ccc(Cl)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 2/20 0.48
TP53 P04637 2/20 0.46
TAS2R14 Q9NYV8 3/20 0.42
CXCR3 P49682 1/20 0.42
CYP51A1 Q16850 1/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KCNH2 Q12809 1/20 0.41
NR3C1 P04150 1/20 0.40
KDM4E B2RXH2 1/20 0.39
LIMK2 P53671 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6541179 1.00 MAPT (0.49) MAPTMEN1KMT2APOLBTP53
SCHEMBL6541341 0.89 MAPT (0.42) MAPTMEN1KMT2APOLBTP53
SCHEMBL6541337 0.89 MAPT (0.42) MAPTMEN1KMT2APOLBTP53
SCHEMBL6804967 0.84 ADRB3 (0.47)
SCHEMBL6541539 0.83 MAPT (0.48) MAPTMEN1KMT2APOLBTP53
SCHEMBL6541541 0.83 MAPT (0.48) MAPTMEN1KMT2APOLBTP53
SCHEMBL6541458 0.83 MAPT (0.40) MAPTMEN1KMT2ATP53TAS2R14
SCHEMBL6539998 0.83 RORC (0.42) MAPTMEN1KMT2APOLBTP53
SCHEMBL6540005 0.83 RORC (0.42) MAPTMEN1KMT2APOLBTP53
SCHEMBL6541465 0.83 MAPT (0.40) MAPTMEN1KMT2ATP53TAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 MAPT 4502/4885MEN1 4140/4885KMT2A 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.